BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.700
0.00 (0.00%)
Apr 29, 2025, 1:09 PM EDT - Market open

BioRestorative Therapies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
1310810151
Upgrade
Market Cap Growth
20.83%20.83%-18.93%-33.36%1737.36%275.14%
Upgrade
Enterprise Value
2-3-4-6208
Upgrade
Last Close Price
1.701.431.742.754.3427.60
Upgrade
PS Ratio
32.9124.6856.1784.33329.5610.72
Upgrade
PB Ratio
1.381.160.820.980.70-0.62
Upgrade
P/TBV Ratio
1.621.250.881.070.72-
Upgrade
EV/Sales Ratio
5.05---442.81109.22
Upgrade
Debt / Equity Ratio
--0.020.030.03-3.60
Upgrade
Asset Turnover
0.030.030.010.010.000.03
Upgrade
Quick Ratio
2.912.914.252.4757.812.95
Upgrade
Current Ratio
2.972.974.372.5359.013.05
Upgrade
Return on Equity (ROE)
-96.89%-96.89%-102.66%-82.93%-437.23%-
Upgrade
Return on Assets (ROA)
-58.03%-58.03%-65.50%-60.99%-122.70%-59.17%
Upgrade
Return on Capital (ROIC)
-77.25%-77.25%-91.65%-72.18%-127.82%-
Upgrade
Earnings Yield
-70.38%-90.74%-127.21%-130.88%-292.25%-1366.26%
Upgrade
FCF Yield
-65.34%-84.25%-80.61%-61.16%-22.17%-238.07%
Upgrade
Buyback Yield / Dilution
-84.05%-84.05%-16.60%-204.60%-200.92%-
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q